Novo Nordisk A/S
NYSE: NVO
$131.89
-$1.15 (-0.9%)
Closing price May 17, 2024
NVO Articles
Wasn’t it just last week that we were up eight days in a row on the DJIA? And now we have a sell-the-news reaction to the recent growth numbers. Maybe it is because we ran too far too fast...
Published:
Last Updated:
NYSE Euronext has begun trading a new ETF this week that is meant to track the large companies throughout the Nordic region. This seeks to track the FTSE Nordic 30 Index, which is comprised of the...
Published:
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a recent dig down for...
Published:
Last Updated:
Everyone is on hold for jobs data, but there are still pre-market research calls. These are the top ten analyst calls we saw for upgrades and downgrades this Friday morning: Crocs (CROX) Raised to...
Published:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
Published:
These are the top pre-market analyst upgrades and downgrades this Wednesday morning in early trading. American Water Works (AWK) Started as Buy at Brean Murray. CardioNet (BEAT) Cut to Hold at...
Published:
These are some of the top pre-market analyst upgrades we have seen from Wall Street early this Monday morning: AstraZeneca (AZN) Raised to Buy at UBS. BioMed Realty Trust (BMR) Raised to Outperform...
Published:
These are the top pre-market analyst upgrades and downgrades we have seen early this Tuesday morning with about two hours until the market opens Baidu.com (NASDAQ: BIDU) Started as Buy at Deutsche...
Published:
These are most of the general analyst calls we have seen with downgrades or negative implications this Wednesday morning in the early pre-market trading hours: Allscripts-Misys (NASDAQ: MDRX) Cut to...
Published:
Last Updated:
ZymoGenetics, Inc. (NASDAQ: ZGEN) has filed an SEC registration which would allow the company to sell up to $100 million of its common stock from time to time. What is important to note is that this...
Published:
These are some of the downgrades or cautious analyst calls we are seeing this Thursday morning: AerCap (AER) Cut to Hold at Citigroup. Amerigroup (AGP) Started as Neutral at B of A. Lehman (LEH)...
Published:
Chances are that if you weren’t short selling all day, this was another ugly summer day that made you want to panic. Covering the market wasn’t any more fun either. But imagine that...
Published:
Last Updated:
These are not all of the calls we are seeing in pre-market coverage, but these are ten of the calls impacting shares this Tuesday morning: Adobe (NASDAQ: ADBE) raised to Overweight from Equal Weight...
Published:
Last Updated:
These are not all of the analyst calls affecting shares this morning, but these are ten that we are focusing on this Monday morning: AbitibiBowater (NYSE: ABH) started as Outperform at RBC Capital...
Published: